Reported sales and earnings from the publicly traded cardiovascular device companies in 2018 were generally strong, led by transcatheter aortic valve replacement devices, but some sectors of the industry, especially ventricular assist devices and peripheral drug-coated balloons, face significant challenges. Here's a recap of results from the cardio device companies that have reported so far, with a focus on Medtronic, Edwards, and Abbott.
• Source: shutterstock.com
[Editor's note:Look out for upcoming recaps of earnings reports in the IVD and orthopedics sectors.]
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
